NO20030416D0 - Krystallinsk terapeutisk forbindelse - Google Patents

Krystallinsk terapeutisk forbindelse

Info

Publication number: NO20030416D0
Authority: NO; Norway
Prior art keywords: therapeutic compound; crystalline therapeutic; crystalline; compound; therapeutic
Prior art date: 2000-07-28

Application number

NO20030416A

Other languages

English (en)

Other versions

NO20030416L (no

NO324220B1 (no

Inventor

Laurence James Harris

Richard Anthony Storey

Albert Shaw Wood

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-28

Filing date

2003-01-27

Publication date

2003-01-27

2000-07-28 Priority claimed from GB0018656A external-priority patent/GB0018656D0/en

2001-03-15 Priority claimed from GB0106464A external-priority patent/GB0106464D0/en

2003-01-27 Application filed by Pfizer filed Critical Pfizer

2003-01-27 Publication of NO20030416D0 publication Critical patent/NO20030416D0/no

2003-02-05 Publication of NO20030416L publication Critical patent/NO20030416L/no

2007-09-10 Publication of NO324220B1 publication Critical patent/NO324220B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)

NO20030416A 2000-07-28 2003-01-27 Fremgangsmate for fremstilling av en polymorf NO324220B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0018656A GB0018656D0 (en)	2000-07-28	2000-07-28	Pharmaceutically active compounds
GB0106464A GB0106464D0 (en)	2001-03-15	2001-03-15	Crystalline therapeutic agent
PCT/IB2001/001280 WO2002010171A1 (en)	2000-07-28	2001-07-18	Crystalline therapeutic agent

Publications (3)

Publication Number	Publication Date
NO20030416D0 true NO20030416D0 (no)	2003-01-27
NO20030416L NO20030416L (no)	2003-02-05
NO324220B1 NO324220B1 (no)	2007-09-10

Family

ID=26244756

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030416A NO324220B1 (no)	2000-07-28	2003-01-27	Fremgangsmate for fremstilling av en polymorf

Country Status (45)

Country	Link
EP (1)	EP1305314B1 (no)
JP (1)	JP2004505087A (no)
KR (1)	KR100457937B1 (no)
CN (1)	CN1207297C (no)
AP (1)	AP1400A (no)
AR (1)	AR032628A1 (no)
AT (1)	ATE286901T1 (no)
AU (2)	AU7269001A (no)
BG (1)	BG107266A (no)
BR (1)	BR0112734A (no)
CA (1)	CA2417264C (no)
CZ (1)	CZ2003126A3 (no)
DE (1)	DE60108398T2 (no)
DO (1)	DOP2001000217A (no)
DZ (1)	DZ3364A1 (no)
EA (1)	EA004681B1 (no)
EC (1)	ECSP034454A (no)
EE (1)	EE200300045A (no)
ES (1)	ES2231521T3 (no)
GE (1)	GEP20053494B (no)
HR (1)	HRP20030061A2 (no)
HU (1)	HUP0302982A3 (no)
IL (1)	IL153226A0 (no)
IN (1)	IN2002MU01649A (no)
IS (1)	IS6626A (no)
MA (1)	MA26931A1 (no)
MX (1)	MX233602B (no)
MY (1)	MY117831A (no)
NO (1)	NO324220B1 (no)
NZ (1)	NZ523226A (no)
OA (1)	OA12337A (no)
PA (1)	PA8523501A1 (no)
PE (1)	PE20020277A1 (no)
PH (1)	PH12001001922B1 (no)
PL (1)	PL365133A1 (no)
PT (1)	PT1305314E (no)
SK (1)	SK572003A3 (no)
SV (1)	SV2001000570A (no)
TN (1)	TNSN01112A1 (no)
TW (1)	TWI285643B (no)
UA (1)	UA72631C2 (no)
UY (1)	UY26854A1 (no)
WO (1)	WO2002010171A1 (no)
YU (1)	YU4703A (no)
ZA (1)	ZA200301457B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004072079A1 (en) *	2003-02-11	2004-08-26	Pfizer Limited	Hydrated and anhydrous sildenafil hemi-citrate compound
EA008596B1 (ru)	2003-04-29	2007-06-29	Пфайзер Инк.	5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
US7572799B2 (en)	2003-11-24	2009-08-11	Pfizer Inc	Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
CA2562251C (en)	2004-04-07	2009-04-28	Pfizer Inc.	Pyrazolo'4,3-d pyrimidines
DK1881985T3 (da)	2005-05-12	2011-02-14	Pfizer	Vandfrie krystalliske former af N-Y1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-D]pyrimidin-3-carbonyl¨methansulfonamid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK15532000A3 (sk) *	1998-04-20	2001-12-03	Pfizer Inc.	Pyrazolopyrimidínové inhibítory cgmp pde5 na použitie na liečbu sexuálnych dysfunkcií, spôsob ich prípravy, medziprodukty a farmaceutický prostriedok s ich obsahom
TWI265925B (en) *	1999-10-11	2006-11-11	Pfizer	Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them

2001
- 2001-07-18 AU AU7269001A patent/AU7269001A/xx active Pending
- 2001-07-18 DE DE60108398T patent/DE60108398T2/de not_active Expired - Fee Related
- 2001-07-18 PT PT01951842T patent/PT1305314E/pt unknown
- 2001-07-18 HR HR20030061A patent/HRP20030061A2/hr not_active Application Discontinuation
- 2001-07-18 OA OA1200300008A patent/OA12337A/fr unknown
- 2001-07-18 CN CNB018133924A patent/CN1207297C/zh not_active Expired - Fee Related
- 2001-07-18 JP JP2002515900A patent/JP2004505087A/ja active Pending
- 2001-07-18 MX MXPA03000856 patent/MX233602B/es active IP Right Grant
- 2001-07-18 DZ DZ013364A patent/DZ3364A1/xx active
- 2001-07-18 EE EEP200300045A patent/EE200300045A/xx unknown
- 2001-07-18 EA EA200300079A patent/EA004681B1/ru not_active IP Right Cessation
- 2001-07-18 YU YU4703A patent/YU4703A/sh unknown
- 2001-07-18 EP EP01951842A patent/EP1305314B1/en not_active Expired - Lifetime
- 2001-07-18 WO PCT/IB2001/001280 patent/WO2002010171A1/en not_active Ceased
- 2001-07-18 CA CA002417264A patent/CA2417264C/en not_active Expired - Fee Related
- 2001-07-18 HU HU0302982A patent/HUP0302982A3/hu unknown
- 2001-07-18 IL IL15322601A patent/IL153226A0/xx not_active IP Right Cessation
- 2001-07-18 PL PL01365133A patent/PL365133A1/xx unknown
- 2001-07-18 AU AU2001272690A patent/AU2001272690B2/en not_active Ceased
- 2001-07-18 AT AT01951842T patent/ATE286901T1/de not_active IP Right Cessation
- 2001-07-18 GE GE5062A patent/GEP20053494B/en unknown
- 2001-07-18 ES ES01951842T patent/ES2231521T3/es not_active Expired - Lifetime
- 2001-07-18 CZ CZ2003126A patent/CZ2003126A3/cs unknown
- 2001-07-18 BR BR0112734-9A patent/BR0112734A/pt not_active IP Right Cessation
- 2001-07-18 UA UA2003010715A patent/UA72631C2/uk unknown
- 2001-07-18 SK SK57-2003A patent/SK572003A3/sk not_active Application Discontinuation
- 2001-07-18 KR KR20037001202A patent/KR100457937B1/ko not_active Expired - Fee Related
- 2001-07-18 NZ NZ523226A patent/NZ523226A/en unknown
- 2001-07-24 PE PE2001000746A patent/PE20020277A1/es not_active Application Discontinuation
- 2001-07-25 MY MYPI20013530A patent/MY117831A/en unknown
- 2001-07-26 DO DO2001000217A patent/DOP2001000217A/es unknown
- 2001-07-26 AP APAP/P/2001/002234A patent/AP1400A/en active
- 2001-07-26 UY UY26854A patent/UY26854A1/es not_active Application Discontinuation
- 2001-07-26 PH PH12001001922A patent/PH12001001922B1/en unknown
- 2001-07-26 AR ARP010103576A patent/AR032628A1/es unknown
- 2001-07-27 SV SV2001000570A patent/SV2001000570A/es not_active Application Discontinuation
- 2001-07-27 TW TW090118441A patent/TWI285643B/zh not_active IP Right Cessation
- 2001-07-27 TN TNTNSN01112A patent/TNSN01112A1/fr unknown
- 2001-07-27 PA PA20018523501A patent/PA8523501A1/es unknown
2002
- 2002-11-12 BG BG107266A patent/BG107266A/bg unknown
- 2002-11-18 IS IS6626A patent/IS6626A/is unknown
- 2002-11-20 IN IN1649MU2002 patent/IN2002MU01649A/en unknown
2003
- 2003-01-20 MA MA27003A patent/MA26931A1/fr unknown
- 2003-01-27 NO NO20030416A patent/NO324220B1/no unknown
- 2003-01-28 EC EC2003004454A patent/ECSP034454A/es unknown
- 2003-02-24 ZA ZA200301457A patent/ZA200301457B/en unknown

Also Published As

Publication number	Publication date
AP2001002234A0 (en)	2001-09-30
IN2002MU01649A (no)	2004-12-11
YU4703A (sh)	2006-01-16
MY117831A (en)	2004-08-30
KR20030016430A (ko)	2003-02-26
PE20020277A1 (es)	2002-05-11
AU7269001A (en)	2002-02-13
OA12337A (en)	2006-05-15
CZ2003126A3 (cs)	2004-02-18
DE60108398D1 (de)	2005-02-17
EP1305314B1 (en)	2005-01-12
WO2002010171A1 (en)	2002-02-07
DZ3364A1 (fr)	2002-02-07
DOP2001000217A (es)	2002-10-30
SV2001000570A (es)	2002-09-03
HRP20030061A2 (en)	2003-04-30
NZ523226A (en)	2003-07-25
KR100457937B1 (ko)	2004-11-20
ZA200301457B (en)	2004-04-28
JP2004505087A (ja)	2004-02-19
HK1055954A1 (en)	2004-01-30
HUP0302982A3 (en)	2005-01-28
BG107266A (bg)	2003-07-31
NO20030416L (no)	2003-02-05
ECSP034454A (es)	2003-03-10
SK572003A3 (en)	2004-05-04
CA2417264C (en)	2007-06-12
MXPA03000856A (es)	2003-06-06
ATE286901T1 (de)	2005-01-15
UA72631C2 (uk)	2005-03-15
AR032628A1 (es)	2003-11-19
TWI285643B (en)	2007-08-21
EA200300079A1 (ru)	2003-06-26
PH12001001922B1 (en)	2006-11-21
CN1444585A (zh)	2003-09-24
HUP0302982A2 (hu)	2003-12-29
CN1207297C (zh)	2005-06-22
ES2231521T3 (es)	2005-05-16
AU2001272690B2 (en)	2005-12-08
IS6626A (is)	2002-11-18
MA26931A1 (fr)	2004-12-20
CA2417264A1 (en)	2002-02-07
EP1305314A1 (en)	2003-05-02
NO324220B1 (no)	2007-09-10
IL153226A0 (en)	2003-07-06
PA8523501A1 (es)	2002-10-24
TNSN01112A1 (fr)	2005-11-10
EE200300045A (et)	2004-12-15
EA004681B1 (ru)	2004-06-24
GEP20053494B (en)	2005-04-25
PT1305314E (pt)	2005-04-29
PL365133A1 (en)	2004-12-27
AP1400A (en)	2005-04-28
MX233602B (es)	2006-01-10
BR0112734A (pt)	2004-08-10
UY26854A1 (es)	2002-02-28
DE60108398T2 (de)	2005-12-22

Publication	Publication Date	Title
NO20026196L (no)	2003-02-24	Kinazolinditosylatsalt-forbindelser
DK1619192T3 (da)	2010-03-29	Arylkondeserede azapolycykliske forbindelser
EP1296699A4 (en)	2005-02-16	THERAPEUTIC AGENTS - III
DK1451192T3 (da)	2011-04-04	Ny krystallinsk forbindelse
NO20033205D0 (no)	2003-07-15	Terapeutiske kromanforbindelser
NO20020030L (no)	2002-03-05	Krystallinske 1-metylkarbapenemforbindelser
ID29755A (id)	2001-10-11	Senyawa-senyawa organosilikon
ATE372338T1 (de)	2007-09-15	Deshalogenverbindungen
NO20030303D0 (no)	2003-01-20	Kalsilytiske forbindelser
NO20031837L (no)	2003-06-20	Kalsilytiske forbindelser
NO20023508L (no)	2002-07-23	Kalsilyttiske forbindelser
TR200100070A3 (tr)	2001-08-21	Bilesim
NO20030416L (no)	2003-02-05	Krystallinsk terapeutisk forbindelse
NO20024679L (no)	2002-09-30	Krystallinsk farmasöytikum
SE0001422D0 (sv)	2000-04-17	Crystalline form
SE0001187D0 (sv)	2000-04-03	Crystalline form
SE0003368D0 (sv)	2000-09-21	Therapeutic compounds
SE0004825D0 (sv)	2000-12-22	Therapeutic compounds
SE0004826D0 (sv)	2000-12-22	Therapeutic compounds
SE9904417D0 (sv)	1999-12-03	Crystalline form
SE0002921D0 (sv)	2000-08-16	Pharmaceutically useful compounds
SE0002922D0 (sv)	2000-08-16	Pharmaceutically useful compounds
SE0004458D0 (sv)	2000-12-01	Pharmaceutically useful compounds
SE0004680D0 (sv)	2000-12-18	New compound
SE0003477D0 (sv)	2000-09-28	Compounds